Cart
sales@molnova.com
Mebeverine acid
CAS No. 475203-77-1
Mebeverine acid( Mebeverine metabolite Mebeverine acid )
Catalog No. M26292 CAS No. 475203-77-1
Mebeverine acid is a secondary metabolite of Mebeverine and can be used as a marker of oral exposure to Mebeverine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 266 | Get Quote |
|
| 10MG | 386 | Get Quote |
|
| 25MG | 659 | Get Quote |
|
| 50MG | 981 | Get Quote |
|
| 100MG | 1494 | Get Quote |
|
| 200MG | 2277 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMebeverine acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMebeverine acid is a secondary metabolite of Mebeverine and can be used as a marker of oral exposure to Mebeverine.
-
DescriptionMebeverine acid is a secondary metabolite of Mebeverine and can be used as a marker of oral exposure to Mebeverine.
-
In Vitro——
-
In Vivo——
-
SynonymsMebeverine metabolite Mebeverine acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorNa+ channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number475203-77-1
-
Formula Weight279.38
-
Molecular FormulaC16H25NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 13.33 mg/mL (47.71 mM)
-
SMILESCCN(CCCC(O)=O)C(C)Cc1ccc(OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.A Sunami, et al. A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2326-31.
molnova catalog
related products
-
WL 47 - dimer
High affinity caveolin-1 (CAV1) ligand (Kd = 23 nM); disrupts caveolin-1 oligomers. Exhibits selectivity for CAV1 over BSA, casein and HEWL.
-
Pomalidomide 4'-PEG2...
Pomalidomide 4'-PEG2-azide is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a linker.
-
VULM 1457
VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes.
